Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07JOZ
|
||||
Former ID |
DNC009341
|
||||
Drug Name |
1,1':4',1''-terphenyl-3,3''-diol
|
||||
Synonyms |
[1,1':4',1'']Terphenyl-3,3''-diol
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530450] | ||
Structure |
Download2D MOL |
||||
Formula |
C18H13FO2
|
||||
Canonical SMILES |
C1=CC(=CC(=C1)O)C2=CC=C(C=C2)C3=CC(=C(C=C3)O)F
|
||||
InChI |
1S/C18H13FO2/c19-17-11-15(8-9-18(17)21)13-6-4-12(5-7-13)14-2-1-3-16(20)10-14/h1-11,20-21H
|
||||
InChIKey |
JNOWDEFWQPRYLB-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cytochrome P450 3A4 | Target Info | Inhibitor | [529748] | |
Estradiol 17 beta-dehydrogenase 1 | Target Info | Inhibitor | [530450] | ||
KEGG Pathway | Steroid hormone biosynthesis | ||||
Linoleic acid metabolism | |||||
Retinol metabolism | |||||
Metabolism of xenobiotics by cytochrome P450 | |||||
Drug metabolism - cytochrome P450 | |||||
Drug metabolism - other enzymes | |||||
Metabolic pathways | |||||
Bile secretion | |||||
Chemical carcinogenesishsa00140:Steroid hormone biosynthesis | |||||
Ovarian steroidogenesis | |||||
NetPath Pathway | FSH Signaling Pathway | ||||
PANTHER Pathway | Androgen/estrogene/progesterone biosynthesis | ||||
WikiPathways | Metapathway biotransformation | ||||
Aflatoxin B1 metabolism | |||||
Estrogen metabolism | |||||
Benzo(a)pyrene metabolism | |||||
Tamoxifen metabolism | |||||
Tryptophan metabolism | |||||
Oxidation by Cytochrome P450 | |||||
Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
Nuclear Receptors Meta-Pathway | |||||
Farnesoid X Receptor Pathway | |||||
Vitamin D Receptor Pathway | |||||
Felbamate Metabolism | |||||
Lidocaine metabolism | |||||
Nifedipine Activity | |||||
Colchicine Metabolic Pathway | |||||
Irinotecan Pathway | |||||
Drug Induction of Bile Acid Pathway | |||||
Fatty Acid Omega Oxidation | |||||
Codeine and Morphine MetabolismWP496:Steroid Biosynthesis | |||||
Metabolism of steroid hormones and vitamin D | |||||
Prostate Cancer | |||||
References | |||||
Ref 529748 | J Med Chem. 2008 Nov 13;51(21):6725-39. Epub 2008 Oct 15.Design, synthesis, biological evaluation and pharmacokinetics of bis(hydroxyphenyl) substituted azoles, thiophenes, benzenes, and aza-benzenes as potent and selective nonsteroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1). | ||||
Ref 530450 | J Med Chem. 2009 Nov 12;52(21):6724-43.New insights into the SAR and binding modes of bis(hydroxyphenyl)thiophenes and -benzenes: influence of additional substituents on 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) inhibitory activity and selectivity. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.